Canaccord Genuity analyst Max Masucci reiterated a Buy rating on Exact Sciences (EXAS – Research Report) on January 13 and
Category: Healthcare
William Blair Reaffirms Their Hold Rating on Audentes Therapeutics (BOLD)
In a report released today, Raju Prasad from William Blair maintained a Hold rating on Audentes Therapeutics (BOLD – Research
Cowen & Co. Sticks to Its Buy Rating for Nektar Therapeutics (NKTR)
In a report released today, Chris Shibutani from Cowen & Co. maintained a Buy rating on Nektar Therapeutics (NKTR –
Cowen & Co. Sticks to Their Buy Rating for Gritstone Oncology (GRTS)
In a report released today, Marc Frahm from Cowen & Co. reiterated a Buy rating on Gritstone Oncology (GRTS –
Cowen & Co. Maintains a Buy Rating on Alnylam Pharma (ALNY)
In a report released today, Ritu Baral from Cowen & Co. maintained a Buy rating on Alnylam Pharma (ALNY –
PTC Therapeutics (PTCT) Receives a Buy from William Blair
In a report released today, Raju Prasad from William Blair maintained a Buy rating on PTC Therapeutics (PTCT – Research
NuVasive (NUVA) Receives a Hold from Robert W. Baird
In a report released today, Jeff Johnson from Robert W. Baird maintained a Hold rating on NuVasive (NUVA – Research